Gold eases as U.S. data, vaccine hopes dent safe-haven demand
"A general pro-growth stance across markets is why we`re seeing a little bit of pressure on gold," said Michael McCarthy, chief strategist at CMC Markets, adding that market action reflected a tussle between concerns over rising cases and hopes for a vaccine and positive U.S. data.
Gold edged lower on Thursday, easing from a near eight-year peak hit in the last session, as solid U.S. manufacturing data and promising results from a COVID-19 vaccine trial, Photo: Reuters